ABSTRACT
INTRODUCTION
Small bowel ulcers and strictures in children are commonly caused by inflammatory bowel disease (IBD), nonsteroidal anti-inflammatory drugs (NSAIDs)-associated enteritis, cytomegalovirus-related gastrointestinal (GI) disease, tuberculous enteritis, and intestinal lymphoma. Most of the aforementioned conditions usually require mucosal or tissue biopsy or even tissue resection and histopathology. Differential diagnosis of other less common conditions should be considered after certain diseases have been ruled out (e.g., IBD, infection, cancer). Cryptogenic multifocal ulcerous stenosing enteritis (CMUSE) is a rare condition that has been reported in both adults and children (1) . A proposed diagnosis of CMUSE can be made after excluding other diseases. Moreover, the treatment for this condition is not well-established and the prognosis also remains uncertain. Some reports also noted poor prognosis with frequent recurrence (2) . We herein report a girl who had a longstanding history of iron deficiency anemia (IDA) and later was noted to have protein-losing enteropathy. Laborious investigations including surgical resection of the stricture site aid in making a provisional diagnosis of CMUSE.
CASE PRESENTATION
A 10-year-old girl presented with a 7-year history of refractory IDA. She denied abdominal pain, nausea or vomiting, rash, joint pain, bloody stools, constipation, or diarrhea. Her nutritional history was reportedly normal. History of drug use including NSAIDs was also denied. She had been given iron supplementation since she was 3 years old, but the iron status did not improve. At the age of 7 years, her anemia worsened. She received two red blood cell transfusions and underwent upper GI endoscopy that showed small duodenal ulcer. Histopathology showed organizing ulcer without Helicobacter pylori. When she was 8 years old, her anemia again worsened. Endoscopic and histologic examinations of the repeated upper GI endoscopy and colonoscopy were also normal. The iron supplementation was continued in conjunction with a proton pump inhibitor. Almost a year later, she was referred to our institution with refractory IDA.
Her past medical history was significant for rupture appendicitis and underwent appendectomy. No demonstrable history of GI problems in the family or close contact to cases with tuberculosis. Besides iron supplementation and acid blockade, no other drug use was noted. Body weight and height were both at the 10 th percentiles. She was noted to have pale conjunctivae but other examinations were unremarkable without signs of extraintestinal presentation of IBD. There were no red or white blood cell in the microscopic stool examination or urinalysis, but stool Guaiac test was positive in three occasions. The initial laboratory investigations were the following: white blood cells 7.920/mm 3 (N 46%, L 47%, E 4%), hemoglobin 8 g/dL with MCV 68 fL, and platelet count 599.000/ mm 3 with transferrin saturation 2.8% (normal: >16) compatible with IDA. Liver transaminases were within normal limits, but hypoalbuminemia (serum protein 42 g/L, serum albumin 18.3 g/L) was documented. Urine protein was negative. Spot stool for alpha-1 antitrypsin was high at 37.3 mg/dL (normal: <5). Erythrocyte sedimentation rate and C-reactive protein were both within the normal range. Another repeated upper GI endoscopy and colonoscopy (third endoscopy) was normal, and histopathology showed no signs of IBD or infection. Purified protein derivative skin test, stool acid fast bacilli, and small intestinal tissue biopsy for tuberculosis polymerase chain reaction (PCR) were all negative.
The upper GI and small bowel follow-through contrast study showed no definite evidence of abnormal bowel dilatation or obstruction. Subsequently, being able to define possible mucosal lesions in the small bowel, video capsule enteroscopy was performed (Figure 1 ), which demonstrated a single ulcer in the proximal jejunum and few circumferential ulcerations causing strictures and bleeding in the mid-to-distal small bowel. Unfortunately, the capsule retained in the small bowel. Retrograde double balloon enteroscopy was performed to remove the capsule. Enteroscopy showed the following: (i) diffuse swelling and inflammation just above the ileocecal valve (ICV); (ii) two 0.5-1.5 cm, 1/4-1/2 circumferential ulcers were seen at 30-40 cm above ICV; and (iii) a tight stricture site 50 cm from the ICV. Contrast study through the enteroscopy showed pre-stenotic dilatation, few stricture sites, and a capsule 10 cm proximal to the tight stricture. Again, histopathology of the terminal ileum showed reactive lymphoid follicle without picture of IBD, drug-related ileitis, or specific infection. The patient remained asymptomatic. The pediatric surgery team was then consulted for capsule removal. The initial plan was to try reducing inflammation and swelling with systemic corticosteroids (prednisolone 2 mg/kg/day), which may lead to capsule expulsion. However, after 3 weeks of prednisolone, plain Multiple out-pouching lesions, swelling, and inflammatory spots were found along the ileum 45 cm up from the capsule-stricture point radiograph confirmed capsule retention. Therefore, exploratory laparotomy was performed. The capsule retained at 50 cm from the ICV. Small intestinal wall was dilated proximal to the stricture site with small intraluminal ulcers and scar. Multiple out-pouching lesions, swelling, and inflammatory spots were also found 45 cm up from the stricture site. Segmental ileal resection (about 7 cm in length) with end-to-end anastomosis was performed ( Figure 2 ). Histopathology revealed acute ulcerative inflammation without picture of IBD or infection. At this time, a presumptive diagnosis was CMUSE, according to the clinical diagnostic criteria.
Systemic corticosteroid was again resumed at 2 mg/ kg/day. Anemia and hypoalbuminemia improved after 6 weeks (hemoglobin 10.2 g/dL and albumin 23.8 g/L). The side effects of systemic corticosteroid were not observed. Then, the steroid was weaned, and azathioprine was initiated at 1 mg/kg/day as a steroid-sparing agent. After following for 10 months, hemoglobin and albumin increased to 13.2 and 34 g/L, respectively. The spot stool for alpha-1 antitrypsin decreased to 8.3 mg/dL. Magnetic resonance enterography was performed and still demonstrated a focal narrowing of the terminal ileum associated with mild contrast enhancement of the bowel wall, suggestive of mild inflammatory process. No evidence of obstruction, fistula, or abscess formation. She remained asymptomatic with a weight gain of 5 kilograms in 10 months, with a low dose of corticosteroid and azathioprine.
We obtained an informed consent from the patient's caregiver.
DISCUSSION
Cryptogenic multifocal ulcerous stenosing enteritis is a rare idiopathic cause of ulceration and stricture of small bowel, which can be presented with acute or chronic GI bleeding, symptoms of bowel obstruction, abdominal pain, anemia, hypoalbuminemia, and perforation (1) (2) (3) (4) (5) .
Most aforementioned studies demonstrated case series of patients with CMUSE, which were mainly diagnosed during adulthood and only few were diagnosed before the age of 10 years. Etiology and pathogenesis is still unknown and poorly understood but may be related with X-link recessive reticulate pigmentary disorder, heterozygosity of the cytoplasmic phospholipase A2-a gene (3), and mutation of SLOCO2A1 gene (6, 7) . Characteristics of small intestinal lesions can be defined by radiologic investigations such as contrast study, macroscopic examination via capsule or balloon enteroscopy, or surgical specimens.
Differential diagnoses of CMUSE include IBD especially Crohn's disease, NSAIDs-associated enteritis, intestinal lymphoma, or infectious enteritis such as cytomegalovirus or tuberculosis. Location of lesion, clinical symptoms, and radiographic findings can be similar between IBD and CMUSE, but IBD usually has a histopathological picture of "chronicity" on intestinal biopsy. Extraintestinal manifestations are usually seen in IBD, but not in CMUSE (8).
Matsumoto et al. (5) reported that 81% of the reported cases during the second to third decades of life had longstanding anemia similar to our patient, and 9 of 15 cases had symptoms for >10 years before a final diagnosis was made by abnormal small bowel findings . More recent studies also reported a long period of time between the symptom onset to the proposed diagnosis (2,3). Our reported patient started having IDA without obvious GI symptoms since the case was 3 years old and was diagnosed with CMUSE at the age of 10 years.
To our knowledge, there is no specific guideline for treating this condition. Systemic corticosteroids may help but most patients develop corticosteroid dependent (1). Chung et al. (2) found a response rate of corticosteroid was approximately 25%. To be able to wean corticosteroid, we attempted to use azathioprine as a maintenance immunomodulator that is frequently used in IBD. Surgical treatment has been reported to have a role in patients with suspected CMUSE with a sign of bowel obstruction or if the diagnosis remains uncertain. Prognosis also remains uncertain due to a paucity of evidence in children. The recurrence rate of disease was reportedly high even after surgery or corticosteroid treatment among adults (2,4).
Informed Consent: Informed consent was obtained from patient's caregiver who participated in this study.
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